Skip to Main Content

Advertisement intended for health care professionals

American Society of Hematology Logo Open Menu
Cart
header search
Search
Skip Nav Destination

Literature Scan

New and noteworthy research from the medical literature landscape
ATRA-ATO Combination Therapy Improves Efficacy for Newly Diagnosed, High-Risk Acute Promyelocytic Leukemia Over Standard of Care Free
Anna Azvolinsky, PhD
November 20, 2025
Phase II Study Confirms Pemigatinib Efficacy, Tolerability in Myeloid, Lymphoid Neoplasms With FGFR1 Rearrangements Free
Katie Robinson
November 13, 2025
Study Uncovers Infection Burden Among Patients with Smoldering Myeloma Free
Anna Azvolinsky, PhD
November 13, 2025
Hematologic Toxicities Affect Efficacy Outcomes of BCMA CAR T-Cell Therapy in Multiple Myeloma, Study Shows Free
Anna Azvolinsky, PhD
October 30, 2025
Serial Serum Free Light Chain Measurement Enhances Monitoring Response, Progression in Multiple Myeloma Free
Pinky Sharma
October 30, 2025
Delayed CAR-T Associated With Worse Outcomes in DLBCL, Study Finds Free
Thomas R. Collins
October 30, 2025
New Analysis Identifies Predictors of Durable 15-Year PFS in Real-World Analysis of MM Free
Leah Lawrence
October 28, 2025
Erythroid-Predominant MDS Shows Specific Genetic Features, Poor Outcomes With Venetoclax Free
Katie Robinson
October 28, 2025
Off-the-Shelf NK Cell Therapy Shows Safety, Activity in R/R B-Cell Lymphoma Free
Pinky Sharma
October 16, 2025
EMD Linked to Severe Toxicities After CAR T-Cell Therapy in MM Free
Katie Robinson
September 26, 2025
p53 IHC Testing May Be Reliable Surrogate for Early Identification of TP53-Mutated MDS, AML Free
Leah Lawrence
September 26, 2025
Study Shows Modest Increased Risk of VTE in Patients With CHIP Free
Ruth Jessen Hickman, MD
September 26, 2025
Intermediate Dose of Cytarabine as Effective as Higher Dose for Post-Induction in AML Free
Lara C. Pullen, PhD
September 26, 2025
Phase IIIb Results Show Avatrombopag to Be Safe, Effective Treatment for Children With ITP Free
Lara C. Pullen, PhD
August 29, 2025
IMS-IMWG Releases New Consensus Definition of High-Risk MM Based on Genomics Free
Katie Robinson
August 29, 2025
Cyclosporin-Cyclophosphamide Performs Well for GVHD Prevention After Transplant Free
Thomas R. Collins
August 29, 2025
Reconceptualizing High ED Use in Patients With SCD Free
Ruth Jessen Hickman, MD
August 13, 2025
Individualized Therapy Associated With Greater Rates of Undetectable MRD, Extended PFS in CLL Free
Khylia Marshall
August 13, 2025
Subcutaneous Isatuximab Noninferior to IV Administration in R/R MM Free
Tess Stafford
August 13, 2025
Long-Term Data Confirm Early Rituximab Monotherapy Delays New Treatment in Advanced, Asymptomatic LTBFL Free
Katie Robinson
July 31, 2025

Advertisement intended for health care professionals

Connect with us:

CURRENT ISSUE
Mid-November 2025

Advertisement intended for health care professionals

  • American Society of Hematology
  • 2021 L Street NW, Suite 900
  • Washington, DC 20036
  • TEL +1 202-776-0544
  • FAX +1 202-776-0545

ASH Publications

American Society of Hematology

Copyright 2025 by American Society of Hematology
 
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals